Tingmin Yu

483 total citations
19 papers, 191 citations indexed

About

Tingmin Yu is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Tingmin Yu has authored 19 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 9 papers in Pathology and Forensic Medicine and 5 papers in Surgery. Recurrent topics in Tingmin Yu's work include Migraine and Headache Studies (14 papers), Trigeminal Neuralgia and Treatments (8 papers) and Cardiovascular Syncope and Autonomic Disorders (4 papers). Tingmin Yu is often cited by papers focused on Migraine and Headache Studies (14 papers), Trigeminal Neuralgia and Treatments (8 papers) and Cardiovascular Syncope and Autonomic Disorders (4 papers). Tingmin Yu collaborates with scholars based in China, United States and Switzerland. Tingmin Yu's co-authors include Qian Huang, Xing‐Mei Zhang, Robert A. Harris, Ping Wang, Gang Yao, Dihui Ma, Ye Gong, Gang Yao, Chunli Yang and Zhihui Dong and has published in prestigious journals such as Neurology, Medicine and Neuroscience Letters.

In The Last Decade

Tingmin Yu

19 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tingmin Yu China 10 102 71 51 31 27 19 191
Tomoko Takamatsu Japan 10 161 1.6× 27 0.4× 39 0.8× 6 0.2× 45 1.7× 17 252
Gábor Gaszner Ireland 4 30 0.3× 18 0.3× 77 1.5× 40 1.3× 147 5.4× 5 348
Richard Tang‐Wai Canada 10 110 1.1× 16 0.2× 12 0.2× 18 0.6× 54 2.0× 15 294
Gary A. Mellick United States 8 81 0.8× 40 0.6× 134 2.6× 7 0.2× 25 0.9× 11 270
Vanêssa Gomes Fraga Brazil 9 19 0.2× 19 0.3× 104 2.0× 11 0.4× 70 2.6× 23 278
Alexandra Dimitrova United States 6 56 0.5× 18 0.3× 69 1.4× 4 0.1× 10 0.4× 13 251
Daniela Briceno Noriega Netherlands 6 90 0.9× 18 0.3× 43 0.8× 24 0.8× 42 1.6× 11 286
Svetlana Tomić Croatia 9 35 0.3× 12 0.2× 37 0.7× 8 0.3× 25 0.9× 20 305
Sonja M. Bragg United States 6 68 0.7× 40 0.6× 57 1.1× 8 0.3× 5 0.2× 9 134
Carla Jevoux Brazil 12 241 2.4× 143 2.0× 82 1.6× 2 0.1× 10 0.4× 43 322

Countries citing papers authored by Tingmin Yu

Since Specialization
Citations

This map shows the geographic impact of Tingmin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingmin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingmin Yu more than expected).

Fields of papers citing papers by Tingmin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingmin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingmin Yu. The network helps show where Tingmin Yu may publish in the future.

Co-authorship network of co-authors of Tingmin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Tingmin Yu. A scholar is included among the top collaborators of Tingmin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingmin Yu. Tingmin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Mingjie, Jin Wu, Hebo Wang, et al.. (2025). Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China. Cephalalgia. 45(10). 2235416742–2235416742. 1 indexed citations
2.
Yu, Shengyuan, Byung‐Kun Kim, Hebo Wang, et al.. (2022). A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. The Journal of Headache and Pain. 23(1). 146–146. 12 indexed citations
3.
4.
Hu, Bo, Gang Li, Xiaohong Li, et al.. (2022). Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study. The Journal of Headache and Pain. 23(1). 90–90. 18 indexed citations
5.
Wang, Shuu‐Jiun, Byung‐Kun Kim, Hebo Wang, et al.. (2022). Efficacy and Safety of Erenumab 70 mg in Adult Patients with Chronic Migraine: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled DRAGON Study (S31.005). Neurology. 98(18_supplement). 1 indexed citations
6.
Fan, Dongsheng, Zhang Hui, Sujuan Wang, et al.. (2020). Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled study. Neural Regeneration Research. 15(7). 1266–1266. 7 indexed citations
7.
Yu, Tingmin, et al.. (2018). Adult severe encephalitis/encephalopathy with a reversible splenial lesion of the corpus callosum. Medicine. 97(26). e11324–e11324. 9 indexed citations
8.
Huang, Qian, et al.. (2017). Behavioral study of a rat model of migraine induced by CGRP. Neuroscience Letters. 651. 134–139. 25 indexed citations
9.
Dong, Zhihui, et al.. (2016). Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses. Neuroscience Letters. 619. 92–99. 18 indexed citations
10.
Han, Fang, Zhao Jian-jun, Hui Zhang, et al.. (2016). Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial. BMC Complementary and Alternative Medicine. 16(1). 356–356. 10 indexed citations
11.
Wang, Ping, et al.. (2016). Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neuroscience Letters. 620. 1–7. 31 indexed citations
12.
Yu, Shengyuan, Qi Wan, Jiying Zhou, et al.. (2015). A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 7 indexed citations
13.
14.
Yao, Gang, et al.. (2013). Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis.. PubMed. 8(10). 938–47. 14 indexed citations
15.
Qi, Jingjing, et al.. (2012). Non-headache symptoms in a migraine attack. Chinese Journal of Neuromedicine. 11(2). 173–176. 1 indexed citations
16.
Yu, Tingmin, et al.. (2012). Meta-analysis of efficacy of topiramate in migraine prophylaxis.. PubMed. 7(23). 1806–11. 5 indexed citations
17.
Yao, Gang, et al.. (2012). Rizatriptan benzoate influences the endogenous pain modulatory system in a rat model of migraine.. PubMed. 7(2). 131–5. 4 indexed citations
18.
Yu, Tingmin, et al.. (2010). A new variant nummular headache: large diameter accompanied with bitrigeminal hyperalgesia and successful treatment with carbamazepine. Turkish Neurosurgery. 22(4). 506–9. 11 indexed citations
19.
Yu, Tingmin, et al.. (2006). Chemical Structure of Water Soluble Polysaccharide from Spores of Ganoderma lucidum. Zhōnghuá yàoxué zázhì. 41(12). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Takamatsu Breakdown of academic impact, for papers by Gábor Gaszner Breakdown of academic impact, for papers by Richard Tang‐Wai Breakdown of academic impact, for papers by Gary A. Mellick Breakdown of academic impact, for papers by Vanêssa Gomes Fraga Breakdown of academic impact, for papers by Alexandra Dimitrova Breakdown of academic impact, for papers by Daniela Briceno Noriega Breakdown of academic impact, for papers by Svetlana Tomić Breakdown of academic impact, for papers by Sonja M. Bragg Breakdown of academic impact, for papers by Carla Jevoux
Rankless by CCL
2026